Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«IGF1R

Below is an extended IGF1R patents listing. Click here to return to the gene page.

Patents :

US Patent No.Title
7488798 Altered insulin-like growth factor binding proteins
7541453 siRNA targeting aquaporin 4
7547687 Therapeutic treatment methods
7547703 Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments
7547782 Met kinase inhibitors
7550143 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
7550262 PTPN11 (SHP-2) mutations and cancer
7550572 siRNA targeting cell division cycle 20 homolog (CDC20)
7553485 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
7553639 Alpha-synuclein kinase
7566784 Bicyclic heterocycles as kinase inhibitors
7541186 Method of generating human retinal progenitors from embryonic stem cells
7541141 Method of using estrogen-related receptor alpha (ERR.alpha.) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERR.alpha. as a therapeutic target for the treatment of breast cancer
7537762 Human monoclonal antibodies to activin receptor-like kinase-1
7498142 Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
7507811 siRNA targeting KRAS
7510881 Method and kit for the quantitative and/or qualitative detection of components in a sample
7514468 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
7521056 Stably tethered structures of defined compositions with multiple functions or binding specificities
7521191 siRNA targeting connexin 43
7526387 Expression profile algorithm and test for cancer prognosis
7527787 Multivalent immunoglobulin-based bioactive assemblies
7528147 Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
7534792 Pyrrolotriazine kinase inhibitors
7569345 Gene expression markers for breast cancer prognosis
7569684 siRNA targeting gremlin
7595388 siRNA targeting EPH receptor A3 (EPHA3)
7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B)
7598369 siRNA targeting histamine receptor H1
7598370 siRNA targeting polo-like kinase-1 (PLK-1)
7605250 siRNA targeting cAMP-specific phosphodiesterase 4D
7608425 Methods for protein expression in mammalian cells in serum-free medium
7608706 siRNA targeting ras-related nuclear protein
7608707 siRNA targeting survivin
7612178 Anti-IGF-1R antibodies and uses thereof
7612181 Dual variable domain immunoglobulin and uses thereof
7595387 Modified polynucleotides for reducing off-target effects in RNA interference
7592442 siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
7589191 siRNA targeting hypoxia-inducible factor 1
7571055 Systemic lupus erythematosus
7575746 Modified human IGF-IR antibodies
7576197 SiRNA targeting KRAS
7576209 Inhibitors of Akt activity
7579457 siRNA targeting carbonic anhydrase II
7579458 siRNA targeting synuclein, alpha (SNCA-1)
7582461 Kinase and phosphatase assays
7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
7588767 Microorganisms for therapy
7588771 Microorganisms for therapy
7612200 Inhibitors of protein kinases

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.